Reversal of Cardiac Hypertrophy in Transgenic Disease Models by Calcineurin Inhibition
- 30 April 2000
- journal article
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 32 (4) , 697-709
- https://doi.org/10.1006/jmcc.2000.1113
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Pathogenesis of Dilated CardiomyopathyThe American Journal of Pathology, 1999
- L-type calcium channels and GSK-3 regulate the activity of NF-ATc4 in hippocampal neuronsNature, 1999
- Calcineurin Inhibition and Cardiac HypertrophyScience, 1998
- Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy.Journal of Clinical Investigation, 1998
- Myofibril degeneration caused by tropomodulin overexpression leads to dilated cardiomyopathy in juvenile mice.Journal of Clinical Investigation, 1998
- Differential activation of transcription factors induced by Ca2+ response amplitude and durationNature, 1997
- Molecular mechanisms regulating the myofilament response to Ca2+: Implications of mutations causal for familial hypertrophic cardiomyopathyBasic Research in Cardiology, 1997
- QUANTITATING IMMUNOSUPPRESSIONTransplantation, 1996
- Reversal of hypertrophyCurrent Opinion in Cardiology, 1995
- Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute Workshop)The American Journal of Cardiology, 1992